1
The change in EFV was significantly correlated with the change in BMI.
2
An increased incidence of adverse pregnancy outcomes was observed in the EFV group.
3
Primary endpoint was the change in EFV at 12 weeks.
4
Moreover, these mRNA expression changes correlated with trunk fat change in the EFV arm.
5
All had taken EFV for at least 4 weeks.